Literature DB >> 19305938

Dimensional, non-taxonic latent structure of psychotic symptoms in a student sample.

E Daneluzzo1, P Stratta, S Di Tommaso, R Pacifico, I Riccardi, A Rossi.   

Abstract

INTRODUCTION: We examined the construct of psychosis using the self-report instrument CAPE (Community Assessment of Psychic Experiences) in a sample of 1,323 students.
MATERIALS AND METHODS: Taxometric analysis was carried out using Taxometric Programs for the R Computing Environment. The MAXCOV CCFI was 0.34, indicating a dimensional latent structure. All other taxometric analysis yielded very similar results indicative of dimensional structure.
CONCLUSION: In this study, using powerful analytic techniques designed expressly for the purpose, i.e. taxometric analysis, the latent construct of psychosis in a sample of young students appeared to be consistent with a dimensional, non-taxonic latent structure.

Entities:  

Mesh:

Year:  2009        PMID: 19305938     DOI: 10.1007/s00127-009-0028-2

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  14 in total

1.  Screening for psychosis in the general population with a self-report interview.

Authors:  W W Eaton; A Romanoski; J C Anthony; G Nestadt
Journal:  J Nerv Ment Dis       Date:  1991-11       Impact factor: 2.254

2.  [The Community Assessment Psychic Experience (CAPE): evaluation study of the Italian version].

Authors:  Enrico Daneluzzo; Silvia Di Tommaso; Daniela Tempesta; Gianluigi Cerroni; Paolo Stratta; Alessandro Rossi
Journal:  Epidemiol Psichiatr Soc       Date:  2008 Jul-Sep

3.  A survey of delusional ideation in primary-care patients.

Authors:  H Verdoux; S Maurice-Tison; B Gay; J Van Os; R Salamon; M L Bourgeois
Journal:  Psychol Med       Date:  1998-01       Impact factor: 7.723

4.  Strauss (1969) revisited: a psychosis continuum in the general population?

Authors:  J van Os; M Hanssen; R V Bijl; A Ravelli
Journal:  Schizophr Res       Date:  2000-09-29       Impact factor: 4.939

5.  Evidence that three dimensions of psychosis have a distribution in the general population.

Authors:  N C Stefanis; M Hanssen; N K Smirnis; D A Avramopoulos; I K Evdokimidis; C N Stefanis; H Verdoux; J Van Os
Journal:  Psychol Med       Date:  2002-02       Impact factor: 7.723

Review 6.  The continuity of psychotic experiences in the general population.

Authors:  L C Johns; J van Os
Journal:  Clin Psychol Rev       Date:  2001-11

7.  How psychotic are individuals with non-psychotic disorders?

Authors:  M Hanssen; F Peeters; L Krabbendam; S Radstake; H Verdoux; J van Os
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2003-03       Impact factor: 4.328

8.  Distributions of hallucinations in the population.

Authors:  A Y Tien
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1991-12       Impact factor: 4.328

Review 9.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder.

Authors:  J van Os; R J Linscott; I Myin-Germeys; P Delespaul; L Krabbendam
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

10.  Validation of the English and French versions of the Community Assessment of Psychic Experiences (CAPE) with a Montreal community sample.

Authors:  Karène Brenner; Norbert Schmitz; Nicole Pawliuk; Ferid Fathalli; Ridha Joober; Antonio Ciampi; Suzanne King
Journal:  Schizophr Res       Date:  2007-08-10       Impact factor: 4.939

View more
  9 in total

1.  How much stress is needed to increase vulnerability to psychosis? A community assessment of psychic experiences (CAPE) evaluation 10 months after an earthquake in L'Aquila (Italy).

Authors:  Alessandro Rossi; Silvia di Tommaso; Paolo Stratta; Ilaria Riccardi; Enrico Daneluzzo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-09-20       Impact factor: 5.270

Review 2.  Psychometric Properties of "Community Assessment of Psychic Experiences": Review and Meta-analyses.

Authors:  Winifred Mark; Timothea Toulopoulou
Journal:  Schizophr Bull       Date:  2015-07-06       Impact factor: 9.306

3.  The Latent Taxonicity of Schizotypy in Biological Siblings of Probands With Schizophrenia.

Authors:  Richard J Linscott; Sarah E Morton
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

4.  Associations between psychotic-like symptoms and inattention/hyperactivity symptoms.

Authors:  Tuula Marketta Hurtig; Anja Taanila; Juha Veijola; Hanna Ebeling; Pirjo Mäki; Jouko Miettunen; Marika Kaakinen; Matti Joukamaa; Sebastian Therman; Markus Heinimaa; Marjo-Riitta Järvelin; Irma Moilanen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-11-12       Impact factor: 4.328

5.  The Psychosis Continuum: Testing a Bifactor Model of Psychosis in a General Population Sample.

Authors:  Mark Shevlin; Eoin McElroy; Richard P Bentall; Ulrich Reininghaus; Jamie Murphy
Journal:  Schizophr Bull       Date:  2016-05-24       Impact factor: 9.306

6.  A model of psychosis and its relationship with impairment.

Authors:  Katherine G Jonas; Kristian E Markon
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-01-11       Impact factor: 4.328

7.  A systematic review of genome-wide research on psychotic experiences and negative symptom traits: new revelations and implications for psychiatry.

Authors:  Angelica Ronald; Oliver Pain
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

8.  Dimensional psychotic experiences in adolescence: Evidence from a taxometric study of a community-based sample.

Authors:  Mark J Taylor; Daniel Freeman; Angelica Ronald
Journal:  Psychiatry Res       Date:  2016-04-11       Impact factor: 3.222

9.  Genome-wide analysis of adolescent psychotic-like experiences shows genetic overlap with psychiatric disorders.

Authors:  Oliver Pain; Frank Dudbridge; Alastair G Cardno; Daniel Freeman; Yi Lu; Sebastian Lundstrom; Paul Lichtenstein; Angelica Ronald
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-03-31       Impact factor: 3.568

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.